Tactile Systems Technology (TCMD) Stock Fundamentals, Analysis & Risk Signals

Health score, price, valuation, risk signals, and key metrics at a glance.

Tactile Systems Technology

NasdaqGM•Healthcare•Medical Devices

$22.40+0.08(<0.01%)Pre-market

Market Cap

$503.42M

P/E

20.2x

P/S

1.4x

P/B

2.2x

Tactile Systems Technology, Inc., a medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States. It offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema, phlebolymphedema, lipedema, venous insufficiencies, and other types of edema and leg ulcers; Entre Plus System, a pneumatic compression device for the at-home treatment of lymphedema, chronic edema, venous insufficiency, and chronic wounds. The company also provides Nimbl, a pneumatic compression platform for the treatment of upper extremity lymphedema; Kylee, a mobile application to help patients learn about lymphedema, track their symptoms, and treatment, as well as to share their progress with their doctor; and AffloVest, a portable high frequency chest wall oscillation vest to treat patients with retained pulmonary secretions resulting from bronchiectasis, cystic fibrosis, and various neuromuscular disorders. Tactile Systems Technology, Inc. was incorporated in 1995 and is headquartered in Minneapolis, Minnesota.

How this company scores

GoodMetricSide Score: 74/100

Strongest: Growth (25/25); weakest: Cash & Earnings Quality (15/25).

Profitability19/25

Growth25/25

Balance Sheet & Red Flags15/25

Cash & Earnings Quality15/25

Strengths

Growing revenueRising earningsInterest easily coveredCash-backed earnings

Valuation vs. 5-year range

Today's multiple positioned against its own trailing range — a visual premium/discount check.

P/E · 20.2x5y range 8.7x – 1615.0x

Currently near its 14-quarter median.

P/S · 1.4x5y range 0.7x – 4.2x

Currently near its 20-quarter median.

P/B · 2.2x5y range 1.2x – 6.6x

Watch items

Data-driven signals worth keeping an eye on across the last 8 quarters

High Risk

Margin Pressure

Red Flag

The company posted negative operating margins in recent quarters — core operations are unprofitable.

Earnings Quality

Watch

FCF/Net Income has dropped below 0.7x in 3 quarters — monitor for earnings quality deterioration.

Price & Volume

Market Cap $503.42M

Metrics at a Glance

as of June 2026

Revenue & Profit

Revenue, EBITDA, operating income, net income, EPS, and shares

TTM Revenue: $350.31M
Q. Revenue: $85.70M
TTM EBITDA: $45.03M
TTM Op. Income: $35.03M
Q. Op. Income: $6.83M
TTM Net Income: $24.86M
Q. Net Income: $7.79M
EPS: $0.34
Shares Out.: $22.68M

$350.31M in TTM revenue grew 17.2% YoY, reaching $85.70M last quarter. TTM EBITDA of $45.03M and TTM operating income of $35.03M show growth is flowing through to the bottom line. TTM net income of $24.86M means revenue is converting into profit. Across the last 8 quarters, TTM revenue has risen for 7 consecutive quarters — an improving trend.

Margins

Gross, EBITDA, operating, and net margin trends

Gross Margin: 76.3%
EBITDA Margin: 10.1%
Op. Margin: 8.0%
Net Margin: 9.1%

Op. margin of 8.0% is up 2.8% YoY — cost efficiency is improving. Net margin at 9.1% and gross margin of 76.3% show how much of each revenue dollar survives to profit. Over the past year, operating margin is up 54% — an improving trend.

Price Ratios

P/E, P/S, P/B, EV/EBITDA, FCF yield, and earnings yield

P/E Ratio: 20.2x
P/S Ratio: 1.4x
P/B Ratio: 2.2x

At 20.2x P/E, the stock trades within typical market levels. P/S of 1.4x and P/B of 2.2x provide additional context. Use the growth and margin sections to judge whether the multiple is justified. Across the last 8 quarters, P/E has fallen for 2 consecutive quarters — an improving trend.

Assets & Liabilities

Total assets, cash, debt, book value, and leverage

Total Assets: $279.67M
Cash: $69.85M
Long-Term Debt: N/A
Book Value: $223.84M
D/E Ratio: N/A
Debt/EBITDA: 0.0

Cash Flow

Operating cash flow, free cash flow, FCF margin, and earnings quality

Op. Cash Flow: $3.25M
TTM Free Cash Flow: $26.82M
FCF Margin: 7.7%
FCF / Net Income: 1.1

TTM FCF of $26.82M on $3.25M in operating cash flow. The FCF / Net Income ratio of 1.1x means free cash flow covers net income — earnings are backed by cash. Across the last 8 quarters, free cash flow has fallen for 2 consecutive quarters — a weakening trend.